Clinicopathological presentation of breast cancer patients with different molecular subtypes at Muhimbili National Hospital
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Muhimbili University of Health and Allied Sciences
Abstract
Background: Breast cancer is among the most common (2nd to cervical cancer) incident cancer among women worldwide. In Tanzania, the current proportion of breast cancer is up to 27.76/100,000 population (Globocan 2020). However, mortality is very high in Tanzania due to late-stage disease or aggressive tumour types. Tanzania also is facing a challenge of inadequate resources which then has created a gap in the description of clinicopathological presentations of breast cancer. Prior local studies had some limitations including; exclusion of males, small sample size (n ≈70) and incomplete IHC.
Objectives: To analyze the clinicopathological presentation of breast cancer patients with different molecular subtypes at MNH.
Materials and Methods: This descriptive retrospective cross-sectional Hospital based study included a total of 446 patient data files (male & female) between 2014 and 2019 at MNH. Patients diagnosed with epithelialized breast cancer and complete IHC were included. All patients with incomplete IHC data were excluded. Data was collected using a structured questionnaire and analyzed using SPSS.
Results: In this Study 446 patients met the inclusion criteria including females (98.4%) and 1.6% were males. Most patients came with duration of chief complaint of 24 months (35.9%) and most presented with stage 3 (36.8%) and stage 4 (59.9%). The most common histology type was IDC (83.2%). However, among patients with IDC 36.3% presented with Luminal A and 34.3% presented with Triple negative molecular subtypes. Lastly, the most prevalent molecular subtype was Luminal A (36.3%); followed by Triple negative (34.3%), Luminal B (15%) and lastly HER-2 enriched (14.3%). Nevertheless, Luminal A and Triple negative molecular subtypes are common in patients with stage 3 & 4 disease.
Conclusion: Late presentation was a challenge and was associated with stage 3 & 4 disease and Luminal A and Triple negative subtypes. Lumina A and Triple negative were the commonest molecular subtypes. IDC histology type was the commonest.
Description
Citation
Matemu, F.S. (2021).
